Publications by authors named "Sun M Lim"

Claim this Profile
S
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study.
Kevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, Jessica L Geiger, Marc Oliva, Sun Min Lim

Oral Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicians' perspectives on the government-led first action plan for healthcare reform: the medical payment system in South Korea.
Sun Mi Lim, Kye-Hyun Kim, Ji Yeun Lim, Seog-Kyun Mun

BMC Health Serv Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Survival Analysis From PERLA, A Phase II Randomized Trial of Dostarlimab With Chemotherapy Versus Pembrolizumab With Chemotherapy in Metastatic Nonsquamous NSCLC.
Sun Min Lim, Ana Laura Ortega Granados, Gustavo Dix Junqueira Pinto, Christian Sebastián Fuentes, Giuseppe Lo Russo

JTO Clin Res Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter Trial.
Sehhoon Park, Hee Kyung Ahn, Seoyoung Lee, Young Joo Min, Jinyong Kim, Sun Min Lim

J Thorac Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-small cell lung cancer: Patient satisfaction and resource utilization results from the PALOMA-3 study.
Mariam Alexander, Ying Cheng, Se-Hoon Lee, Antonio Passaro, Alexander I Spira, Sun Min Lim

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Is On the Horizon for the Diagnosis and Treatment of SCLC and Large Cell Neuroendocrine Cancer?
Sun Min Lim, Joo Sung Gabriel Shim, Hyo Sup Shim, Junko Tanizaki, Jorn Nutzinger

JTO Clin Res Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D3S-001 in advanced solid tumors with KRAS mutations: a phase 1 trial.
Byoung Chul Cho, Shun Lu, Myung Ah Lee, Zhengbo Song, John J Park, Sun Min Lim

Nat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab and bevacizumab, with or without radiotherapy, versus docetaxel in patients with metastatic non-small cell lung cancer previously treated with a checkpoint inhibitor and chemotherapy: results from the randomized, phase Ib/II MORPHEUS-Lung study.
Francois Ghiringhelli, Yaacov R Lawrence, Enriqueta Felip, Alona Zer, Laurent Greillier, Farah Louise Lim, Sun Min Lim

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of thyroid radiation dose with thyroid dysfunction in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy followed by maintenance immunotherapy.
Gowoon Yang, Hong In Yoon, Sun Min Lim, Min Hee Hong, Jaeho Cho

Lung Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA).
Jii Bum Lee, Su-Jin Choi, Hyo Sup Shim, Byung Jo Park, Chang Young Lee, Sun Min Lim

J Thorac Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab.
Dong Kwon Kim, Chun-Bong Synn, Wongeun Lee, Ha-Ni Jo, Chai Young Lee, Sun Min Lim

Mol Cancer Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of lazertinib and amivantamab combination therapy as a treatment strategy for uncommon EGFR-mutated NSCLC.
Seung Yeon Oh, Sewon Park, Seoyoung Lee, Eun Ji Lee, Tae Ho Kim, Sun Min Lim

Cell Rep Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma.
Yongsik Sim, Beomseok Sohn, Sooyon Kim, Hye Ryun Kim, Min Hee Hong, Sun Min Lim

Future Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.
Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna R Minchom

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lazertinib in EGFR-Variant Non-Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors: A Nonrandomized Controlled Trial.
Min Hee Hong, Yoon Ji Choi, Hee Kyung Ahn, Sun Min Lim, Bhumsuk Keam

JAMA Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer.
Sun Min Lim, Stefanie S Schalm, Eun Ji Lee, Sewon Park, Chiara Conti

Ther Adv Med Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea.
Joo Sung Shim, Youhyun Kim, Taeho Yuh, Jii Bum Lee, Hye Ryun Kim, Sun Min Lim

Lung Cancer (Auckl)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy followed by definitive local treatment in locally advanced sinonasal squamous cell carcinoma.
Jina Kim, Min Hee Hong, Hye Ryun Kim, Sun Min Lim, Chang Gon Kim

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D3S-001, a KRAS G12C Inhibitor with Rapid Target Engagement Kinetics, Overcomes Nucleotide Cycling, and Demonstrates Robust Preclinical and Clinical Activities.
Jing Zhang, Sun Min Lim, Mi Ra Yu, Cheng Chen, Jia Wang

Cancer Discov· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.
Joel Neal, Nick Pavlakis, Sang-We Kim, Yasushi Goto, Sun Min Lim

J Clin Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.
Sun M Lim, Seong-San Kang, Dong K Kim, Soo-Hwan Lee, Chun-Bong Synn

Cancer Res Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice recommendations for the use of next-generation sequencing in patients with solid cancer: a joint report from KSMO and KSP.
Miso Kim, Hyo Sup Shim, Sheehyun Kim, In Hee Lee, Jihun Kim, Sun Min Lim

J Pathol Transl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12).
Dong Ki Lee, Sook Ryun Park, Yeul Hong Kim, Yun-Gyoo Lee, Su-Jin Shin, Sun Min Lim

Oncoimmunology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex analysis for the identification of plasma protein biomarkers for predicting lung cancer immunotherapy response.
Moonki Hong, Sang Wook Lee, Byoung Chul Cho, Min Hee Hong, Sun Min Lim

Ther Adv Med Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer types.
Dong Kwon Kim, Chai Young Lee, Yu Jin Han, So Young Park, Heekyung Han, Sun Min Lim

Front Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis